Feb 27 (Reuters) - Mayne Pharma Group Ltd (MYX) :
- MAYNE PHARMA ANNOUNCES SALE OF US RETAIL GENERICS PORTFOLIO TO DR. REDDY'S FOR US$90 MILLION
- AT CLOSING OF SALE, MAYNE PHARMA AND DR. REDDY'S WILL ENTER INTO 10-YEAR SUPPLY AGREEMENT
- SUPPLY AGREEMENT FOR CERTAIN PRODUCTS MANUFACTURED AT MAYNE PHARMA'S FACILITY IN SALISBURY, SOUTH AUSTRALIA
- EXPECTS TO INCUR UP TO US$2 MILLION IN TRANSACTION COSTS AND ESTIMATED US$10 MILLION IN IN ONE-TIME RESTRUCTURING COSTS
- TRANSACTION IS EXPECTED TO CLOSE BY END OF FISCAL YEAR 2023
News: MYX Mayne Pharma Announces Sale Of U.S. Retail Generics Portfolio To Dr. Reddy's For $90 Mln
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.25 |
Change
-0.150(2.78%) |
Mkt cap ! $426.5M | |||
| Open | High | Low | Value | Volume |
| $5.35 | $5.41 | $5.19 | $1.239M | 231.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $5.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.36 | 1000 | 1 |
View Market Depth
| Last trade - 16.11pm 25/07/2025 (20 minute delay) ? |
| MYX (ASX) Chart |